We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

147 hedge funds and large institutions have $453M invested in Avid Bioservices, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 50 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 10

333% more call options, than puts

Call options by funds: $1.39M | Put options by funds: $320K

94% more capital invested

Capital invested by funds: $234M → $453M (+$219M)

67% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 30

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

32% more funds holding

Funds holding: 111147 (+36)

Holders
147
Holders Change
+36
Holders Change %
+32.43%
% of All Funds
2.6%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
46
Increased
50
Reduced
30
Closed
10
Calls
$1.39M
Puts
$320K
Net Calls
+$1.06M
Net Calls Change
+$858K
Name Holding Trade Value Shares
Change
Change in
Stake
KCM
26
Kennedy Capital Management
Missouri
$4.88M +$1.53M +167,601 +66%
LCM
27
Legato Capital Management
California
$4.79M -$409K -44,704 -10%
Morgan Stanley
28
Morgan Stanley
New York
$4.78M +$3.7M +405,202 +4,690%
Goldman Sachs
29
Goldman Sachs
New York
$4.65M +$2.35M +256,782 +176%
IECM
30
Intrinsic Edge Capital Management
Illinois
$4.45M +$3.53M +385,966 New
CCM
31
Cinctive Capital Management
New York
$4.44M +$3.52M +385,000 New
Invesco
32
Invesco
Georgia
$4.37M +$2.29M +250,434 +196%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$4.12M -$306K -33,481 -9%
SIC
34
Schwartz Investment Counsel
Michigan
$3.52M -$229K -25,000 -8%
RA
35
Royce & Associates
New York
$3.21M +$197K +21,500 +8%
Los Angeles Capital Management
36
Los Angeles Capital Management
California
$3.07M -$118K -12,890 -5%
Balyasny Asset Management
37
Balyasny Asset Management
Illinois
$2.88M +$2.29M +250,000 New
EIM
38
Essex Investment Management
Massachusetts
$2.87M -$417K -45,660 -16%
EGI
39
EAM Global Investors
California
$2.65M +$2.1M +229,187 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$2.53M +$34.5K +3,770 +2%
Norges Bank
41
Norges Bank
Norway
$2.27M +$1.8M +197,000 New
Citadel Advisors
42
Citadel Advisors
Florida
$2.1M +$122K +13,293 +8%
EI
43
EAM Investors
California
$1.88M +$1.49M +162,614 New
JP Morgan Chase
44
JP Morgan Chase
New York
$1.88M +$1.26M +137,313 +543%
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$1.87M +$148K +16,202 +12%
SI
46
Stephens Inc
Arkansas
$1.87M +$67.8K +7,413 +5%
MS
47
Maven Securities
Jersey
$1.75M +$1.37M +150,000 New
Wells Fargo
48
Wells Fargo
California
$1.63M +$8.38K +917 +0.7%
Charles Schwab
49
Charles Schwab
California
$1.58M +$58.5K +6,396 +5%
Two Sigma Investments
50
Two Sigma Investments
New York
$1.54M +$1.22M +133,792 New

CDMO Hedge Fund Activity: Q4 2020 in Review

147 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2020, worth a combined $453M — up 94% from $234M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new CDMO positions and 10 closed out — a net gain of 36 holders — while 50 added to existing stakes and 30 trimmed.

The largest buyer was Kornitzer Capital Management, opening a new position worth an estimated $9.46M. The largest seller was Millennium Management, cutting an estimated $18.5M.

  • 147 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2020, up from 111 in Q3 2020.
  • Funds reported $453M of Avid Bioservices, Inc. Common Stock stock for Q4 2020, up 94% quarter-over-quarter.
  • 46 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2020 and 10 closed out, a net change of +36 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2020 was Kornitzer Capital Management, an estimated $9.46M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q4 2020 was Millennium Management, an estimated $18.5M sold.

Based on aggregated 13F filings for Q4 2020.